Regulatory Functions of Protein Tyrosine Phosphatase Receptor Type O in Immune Cells

Feiling Xie1,2, Hongmei Dong1,2, Hao Zhang1,2,3,4

  • 1Institute of Precision Cancer Medicine and Pathology, School of Medicine, Jinan University, Guangzhou, China.

Frontiers in Immunology
|December 9, 2021
PubMed

Insights

Protein tyrosine phosphatase receptor type O (PTPRO) and its truncated form (PTPROt) are crucial in immune cells. This review details their regulatory roles and molecular mechanisms in B cells, T cells, and macrophages.

Area of Science:

  • Immunology
  • Cell Biology
  • Biochemistry

Background:

  • Protein tyrosine phosphatases (PTPs) are critical regulators of cellular signaling pathways.
  • Protein tyrosine phosphatase receptor type O (PTPRO) is an R3 receptor-like PTP.
  • The truncated PTPRO (PTPROt) isoform is predominantly expressed in hematopoietic and immune cells.

Purpose of the Study:

  • To review the regulatory roles of PTPRO and PTPROt in immune cells.
  • To elucidate the molecular mechanisms underlying PTPRO/PTPROt function in immunity.
  • To focus on the impact of PTPRO/PTPROt in B cells, T cells, and macrophages.

Main Methods:

  • Literature review of existing studies on PTPRO and PTPROt.
  • Analysis of signaling pathways regulated by PTPRO/PTPROt.
  • Examination of PTPRO/PTPROt expression patterns in immune cells.

Main Results:

  • PTPROt is significantly expressed in various immune cell types, including B cells, T cells, and macrophages.
  • PTPRO/PTPROt influences key immune cell processes such as growth, differentiation, and activation.
  • Specific molecular mechanisms of PTPRO/PTPROt in immune regulation are being uncovered.

Conclusions:

  • PTPRO and its truncated form PTPROt play vital roles in immune cell function.
  • Understanding PTPRO/PTPROt mechanisms is crucial for comprehending immune responses.
  • Further research into PTPRO/PTPROt is warranted for potential immunomodulatory applications.

Related Concept Videos

Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze...
13.3K
Receptor Tyrosine Kinases01:26

Receptor Tyrosine Kinases

Receptor tyrosine kinases or RTKs are membrane-bound receptors that phosphorylate specific tyrosine on protein substrates. RTKs regulate cellular growth, differentiation, survival, and migration. They contain an extracellular ligand binding domain, a transmembrane domain, and a cytosolic tail with intrinsic kinase activity. Several extracellular signaling molecules activate RTKs in one or more ways and relay the signal downstream. Ligands such as platelet-derived growth factor (PDGF) or...
14.9K
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR...
2.3K
Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
3.1K
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
9.5K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
4.1K